We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease (NIC-PD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2015 by James BOYD MD, University of Vermont.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01560754
First Posted: March 22, 2012
Last Update Posted: September 29, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Michael J. Fox Foundation for Parkinson's Research
Parkinson Study Group (PSG)
International Parkinson Fonds Germany GmbH
German Parkinson Study Group (GPS)
German Parkinson Society (DPG)
Philipps University Marburg Medical Center
Information provided by (Responsible Party):
James BOYD MD, University of Vermont
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)